Valuation Macro Group Pharmaceuticals (Macro Capital) S.A.E

Stocks

End-of-day quote Egyptian Exchange 25/08/2026			5-day change	1st Jan Change
1.510 ^EGP	-0.66%		0.00%	+32.46%

17/05	Macro Group Pharmaceutical Q1 consol profit egp 33.3 million	RE
20/02	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	650	861	-	-
Change	-	32.46%	-	-
Enterprise Value (EV) ¹	650	781.3	751	593
Change	-	20.2%	-3.88%	-21.04%
P/E	5.7x	25.2x	16.8x	13.7x
PBR	-	8.88x	6.86x	5.59x
PEG	-	-0.4x	0.3x	0.6x
Capitalization / Revenue	-	0.72x	0.55x	0.44x
EV / Revenue	-	0.66x	0.48x	0.3x
EV / EBITDA	-	2.88x	1.97x	1.18x
EV / EBIT	-	3.34x	2.09x	1.23x
EV / FCF	-	16.6x	4.2x	1.71x
FCF Yield	-	6.03%	23.8%	58.3%
Dividend per Share ²	-	0.03	0.04	0.06
Rate of return	-	1.99%	2.65%	3.97%
EPS ²	0.2	0.06	0.09	0.11
Distribution rate	-	50%	44.4%	54.5%
Net sales ¹	-	1,190	1,552	1,946
EBITDA ¹	-	271	381	504
EBIT ¹	-	234	360	481
Net income ¹	115.7	206	283	373
Net Debt ¹	-	-79.7	-110	-268
Reference price ²	1.140	1.510	1.510	1.510
Nbr of stocks (in thousands)	5,70,206	5,70,206	-	-
Announcement Date	19/02/26	-	-	-

¹EGP in Million²EGP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E	25.17x	0.66x	2.88x	-	1.71Cr
ELI LILLY AND COMPANY	35.12x	12.73x	25.81x	0.56%	1,10000Cr
JOHNSON & JOHNSON	30.38x	-	-	1.97%	66TCr
ABBVIE INC.	33.92x	7.84x	16.3x	2.58%	47TCr
ROCHE HOLDING AG	20.83x	4.94x	12.23x	2.67%	37TCr
NOVARTIS AG	22.71x	5.84x	14.47x	2.73%	30TCr
ASTRAZENECA PLC	21.88x	4.48x	12.79x	1.96%	26TCr
AMGEN INC.	27.97x	7.21x	12.8x	2.28%	24TCr
NOVO NORDISK A/S	13.99x	4.96x	10.35x	3.67%	21TCr
GILEAD SCIENCES, INC.	-45.46x	6.56x	25.6x	2.22%	18TCr
Average	18.65x	6.13x	14.80x	2.29%	38.03TCr
Weighted average by Cap.	25.31x	8.41x	18.55x	1.89%